Table: Shin Nippon Biomedical - 6-MTH group results

Shin Nippon Biomedical Laboratories

09/11/2018 06:00

Nov 9 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.88                7.55             15.33    
                 (+17.6 pct)         (+6.6 pct)       (-7.7 pct)  
  Operating     loss 137 mln        loss 779 mln        250 mln   
  Recurring        885 mln          loss 640 mln        350 mln   
  Net              912 mln            loss 1.65         600 mln   
  EPS             21.91 yen        loss 39.63 yen      14.41 yen  
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T